Breaking New Twice-Yearly HIV Prevention Drug Begins US Rollout Amidst Equity Concerns Taliban Detains Six Staff Members of Afghan Women’s Rights Group Abdul El-Sayed’s Nomination Highlights Rising Anti-Muslim Sentiment Former Catholic Bishop Convicted of Sexual Abuse Eurovision Implements New Host Eligibility Rules Amid Geopolitical Concerns

Thursday August 13, 2026

Section

PRNewswire

Press Release

Cognizant and Domyn Announce Strategic Partnership to Deliver Sovereign AI Solutions Across EMEA

Cognizant Technology Solutions · Jul 2

Press Release

Intesa Sanpaolo Brings its Digital Infrastructure to Google Cloud Regions in Italy Hosted in TIM’s Data Centers

Google Cloud · Jul 2

Press Release

Summer Davos highlights ‘China Opportunity 2.0’ as new growth engine

chinadiplomacy.org.cn · Jul 2

Press Release

Diplomats, experts explore culture, tech innovation in Wuhan

Changjiang Daily · Jul 2

Press Release

GAC International Posts First-Half Results with Outstanding Performance

GAC · Jul 2

Press Release

As AI Floods Security Teams with Alerts, New Check Point Exposure Management Research Finds Critical Vulnerabilities Have Doubled, Yet Fewer Than 1 in 12 Demand Urgent Action

Check Point Software Technologies · Jul 2

Press Release

BTGO Investors Have Opportunity to Lead BitGo Holdings, Inc. Securities Lawsuit

THE ROSEN LAW FIRM, P. A. · Jul 2

Press Release

Fosun International Garners Five Awards from Corporate Governance Asia

Fosun · Jul 2

Press Release

Jinko ESS and Taliva Energy Sign 400MWh Energy Storage Project Portfolio

Jinko ESS · Jul 1

Press Release

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

Insilico Medicine · Jul 1

Press Release

ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

THE ROSEN LAW FIRM, P. A. · Jul 1

Press Release

Elliott Management Statement on Northern Star Resources Ltd

Elliott Investment Management L.P. · Jul 1

Press Release

Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC

Abbisko · Jul 1

← Previous 1 … 816 817 818 … 856 Next →